ZYUS Life Sciences’ (ZYU) “Buy” Rating Reiterated at Roth Capital
Roth Capital reiterated their buy rating on shares of ZYUS Life Sciences (CVE:ZYU – Free Report) in a report published on Thursday, PriceTargets.com reports. Separately, Stifel Canada reissued a speculative buy rating on shares of ZYUS Life Sciences in a research note on Friday, January 26th. Check Out Our Latest Research Report on ZYUS Life […]
More Stories
Rubio: US Won’t Tolerate Adversaries Controlling Venezuela, Its Oil Reserves
By Emel Akan WASHINGTON—Secretary of State Marco Rubio, speaking Sunday on NBC’s “Meet the Press,” said that the United States...
Trump Praised for Bold, Unprecedented Venezuela Operation
By Emel Akan WASHINGTON—On Saturday morning, Jan. 3, many Americans woke up to news that U.S. special forces had captured...
Much of Maduro’s Security Team Killed in US Action, Venezuela Defense Minister Says
By Jack Phillips A significant portion of Venezuelan socialist leader Nicolás Maduro’s security team was killed in the U.S. operation...
Starlink Provides Free Services for Venezuelans Until Feb. 3
By Jacki Thrapp Elon Musk’s Starlink will offer free services in Venezuela for nearly a month, the company announced in...
New Year’s Gas Prices 23 Cents Cheaper Than a Year Ago in US
By Tom Ozimek American drivers began the new year with further relief at the gas pump, as national average gasoline...
HUD Audit Reveals $5.8 Billion in Potentially Improper Rental Assistance Payments Under Biden
By Naveen Athrappully There was a “significant misuse” of taxpayer funds under the Biden administration concerning rental assistance, which resulted...